The fenofibrate micronized powders were prepared using lactose and MCC as the main expicients for preparation of fenofibrate tablets.

以乳糖和微晶纤维素作为主要辅料非诺贝特微化物,并以此剂,辅以预胶化淀调节剂溶出。

Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.

观察微粒化非诺贝特对IV型高脂血症患者血清低密脂蛋白（LDL）亚组份再分布作用。

Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.

类似，非诺贝特和联合治疗显著升高有浮力LDL在总LDL中比例。